Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05766059

Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation

Paired associative stimulation (PAS) is a non-invasive brain stimulation protocol, where two stimuli (a peripheral and a cortical one, the latter delivered with transcranial magnetic stimulation - TMS) are repeatedly associated to enhance plasticity in the brain. In the present study, a new cross-modal, visuo-motor PAS protocol - called "mirror-PAS"- will be tested as a possible non-invasive brain stimulation treatment in neurological rehabilitation to promote motor recovery and pain reduction.

Participants will perform the standard PAS targeting the motor system and the recently developed mirror-PAS in two separate sessions. The investigators will compare the possible effect of the protocols in terms of neurophysiological and behavioral outcomes to identify the optimal PAS method to enhance plasticity and promote sensory-motor function.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istituto Auxologico Italiano IRCCS

Milan, Lombardy, 20122, Italy

Location status: Recruiting

Location contact

Nadia Bolognini, PhD

CONTACT

[email protected]

+390261911 ext. 6127

About this study

The motor recovery of the upper limb function, particularly of the hand, is challenging in neurological rehabilitation. Transcranial magnetic stimulation (TMS) is a form of non-invasive brain stimulation that can enhance motor recovery, though promoting brain plasticity of the brain.

In this study, researchers will use a TMS protocol called Paired Associative Stimulation (PAS), in which two stimuli (e.g., a cortical stimulus - delivered with TMS - and a peripheral stimulus) are repeatedly associated to promote associative plasticity in the primary motor cortex (M1).

The objective is to explore the clinical efficacy of a newly developed cross-modal PAS protocol -the so-called "mirror-PAS"- as a possible motor rehabilitation treatment in patients with upper limb motor disorders, investigating its neurophysiological and behavioural effects. The innovative aspect of mirror-PAS is to act on a more extended visuomotor network, featured by the functional properties of the mirror neuron system (MNS). Indeed, in the mirror-PAS, a visual stimulus depicting a hand movement is repeatedly paired with a TMS pulse over M1. In the healthy, this protocol was found effective in modulating neurophysiological responses of the motor cortex (i..e, MEPs), hence inducing these effects bypassing the afferent somatosensory pathway exploited by the standard PAS protocols. This may represent a clinical advantage allowing the promotion of motor recovery through the induction of a plastic reorganization in the damaged motor system by gaining access through a potentially spared MNS.

The project's first phase aims to assess the motor and neurophysiological effects of mirror-PAS in stroke patients with upper-limb hemiparesis, compared to the standard excitatory M1-PAS (whose effects are well known in the literature, even if still debated).

In the second phase, we will test the efficacy of the mirror-PAS in a population of amputated patients affected by phantom limb pain (PLP).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for stroke patients:

  • age from 18 to 85 years
  • single, unilateral, hemispheric stroke (cortical or sub-cortical areas)
  • stroke confirmed by neuroimaging (CT or MRI)
  • stroke at least 4 months before enrollment
  • hemiparesis of the upper limb resulting from stroke or hemianesthesia clinically documented

Exclusion criteria

for stroke patients:

  • contraindications to TMS (Rossi et all, 2021)
  • other neurological conditions (e.g., Parkinson's Disease, Multiple Sclerosis, ALS)
  • other orthopedic condition that affected the hand (e.g., carpal tunnel syndrome)

Inclusion criteria

for PLP patients:

  • age from 18 to 90 years
  • amputation of one part of the upper limb at least 2 months before enrollment
  • presence of stable phantom limb pain at least 2 months prior to enrollment

Exclusion criteria

for PLP patients:

  • contraindications to TMS (Rossi et all, 2021)
  • other neurological, orthopedical or psychiatric conditions

Treatment and study plan

Transcranial Magnetic Stimulation

Device

The standard PAS protocol will be compared with the mirrorPAS protocol.

Other names: TMS, Paired associative stimulation

Primary outcomes

  1. Change from baseline in motor-evoked potentials (MEP)

    Time frame: At baseline and after the administration of the PAS protocols

    [Phase 1, only in stroke patients] peak-to-peak MEP amplitude

  2. Change in functional mapping of phantom limb cortical areas

    Time frame: At baseline and after the administration of the PAS protocols

    [Phase 2, only in PLP patients]

Study contacts

Contact information is provided by the study sponsor or research team.

Nadia Bolognini, PhD

CONTACT

[email protected]

+390261911 ext. 6127

Sponsors and collaborators

Lead sponsor

Istituto Auxologico Italiano

Other

Registry information

Official study title

Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation: Cross-modal Paired Associative Stimulation (PAS) Protocols to Promote Plastic Reorganization in Stroke and Phantom Limb Pain Patients

Acronym: StimNeuro

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Mar 13, 2023
Registry last updated
Sep 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.